Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | GLB1 | P16278 | 1/20 | 0.31 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18155964 | 0.95 | APP (0.35) | APPTSHREPHX2GBA1GLB1 | |
| SCHEMBL329331 | 0.81 | GBA1 (0.32) | TSHRGBA1GLB1LMNAALDH1A1 | |
| Sulfuric Acid SCHEMBL4247477 | 0.81 | GBA1 (0.32) | TSHRGBA1GLB1 | |
| SCHEMBL28271612 | 0.79 | GBA1 (0.31) | TSHRGBA1GLB1HTT | |
| Sulfuric Acid SCHEMBL27988212 | 0.79 | GBA1 (0.31) | TSHRGBA1GLB1 | |
| Octane SCHEMBL28171886 | 0.78 | RECQL (0.33) | TSHREPHX2GBA1BLM | |
| SCHEMBL5286518 | 0.77 | EBP (0.36) | TSHRLMNAALDH1A1HTT | |
| SCHEMBL5287172 | 0.77 | GBA1 (0.31) | GBA1GLB1 | |
| Water SCHEMBL27496381 | 0.76 | APP (0.32) | APP | |
| SCHEMBL28814822 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160168447-A1 | HYDROXYPROPYL BETAINE BASED ZWITTERIONIC GEMINAL LIQUIDS, OBTAINING PROCESS AND USE AS WETTABILITY MODIFIERS WITH INHIBITORY/DISPERSANTS PROPERTIES OF ASPHALTENES | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168447-A1 | HYDROXYPROPYL BETAINE BASED ZWITTERIONIC GEMINAL LIQUIDS, OBTAINING PROCESS AND USE AS WETTABILITY MODIFIERS WITH INHIBITORY/DISPERSANTS PROPERTIES OF ASPHALTENES | GEMIN5, GEMIN4, DHCR7 | APP 1175/4885TSHR 4882/4885EPHX2 1188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.